Insider trades

Jason Hoitt, Chief Officer of Stoke Therapeutics STOK, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $119.3K. The latest trade was on 03/18.

Jason Hoitt

Chief Patient Officer
First filing
23/01/11
Trades
16 trades
Buys / sales
0 / 6
12-month net buying
−$119.3K
Last trade
03/18

Trading activity

Transactions

Trade type
STOK
Open-market sale03/17–03/1803/193,712 sh5 trades$32.14avg.$119,308.33−26.5%
Open-market sale23/02/1023/02/144,500 sh$10.00$45,000−100.0%